This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for SHL Telemedicine's Median PS Value or its related term are showing as below:
SHLT'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.32 Med: 1.11 Max: 2.93
Current: 0.34
During the past 13 years, the highest Price to Median PS Value of SHL Telemedicine was 2.93. The lowest was 0.32. And the median was 1.11.
SHLT's Price-to-Median-PS-Value is ranked better than 83.79% of 253
companies
in the Healthcare Providers & Services industry
Industry Median: 0.74
vs SHLT: 0.34
SHL Telemedicine Median PS Value Historical Data
The historical data trend for SHL Telemedicine's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of SHL Telemedicine's Median PS Value
For the Health Information Services subindustry, SHL Telemedicine's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SHL Telemedicine's Price-to-Median-PS-Value Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, SHL Telemedicine's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where SHL Telemedicine's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 2.5947.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. SHL Telemedicine's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was $3.353.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHL Telemedicine (NAS:SHLT) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
SHL Telemedicine's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
3.00
/
8.70
=
0.34
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHL Telemedicine Median PS Value Related Terms
Thank you for viewing the detailed overview of SHL Telemedicine's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. It consists of the transmission of medical data by an individual, from a remote location to a medical call center through telecommunication networks. The company offers solutions to subscribing patients, health insurance companies, hospitals, clinics, and physicians. It provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments Israel, Europe, and the rest of the world, out of which majority revenue comes from Israel.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SHLT has been successfully added to your 